StockGuru Blog: THE IMMUNE RESPONSE CORPORATION PRESIDENT, Joseph F. O’Neill, MD, Discusses Valuation of IMNR
IMNR - The Immune Response Corporation Stock Guru found the new President of The Immune Response Corporation, Dr. Joseph F. O’Neill, on the road today, mid-way during his speaking tour. He took time between speaking engagements to share his opinion on IMNR’s value potential. Dr. O’Neill believes the new direction of IMNR is creating investor value by focusing equally on MS and HIV/AIDS. He also stressed that the IMNR’s multiple sclerosis (MS) program may provide a platform in potentially new applications for autoimmune diseases including psoriasis and rheumatoid arthritis (RA). “We have implemented a new clinical development strategy. We are…